Exploring the Phytochemical Profile and Biological Activities of Clerodendrum infortunatum .
Balakrishnan Syamala AkhilRajimol Puthenpurackal RaviAsha LekshmiPrathapan AbeeshChandrashekharan GuruvayoorappanKokkuvayil Vasu RadhakrishnanKunjuraman SujathanPublished in: ACS omega (2023)
Clerodendrum infortunatum ( C. infortunatum ), the hill glory bower, is reputed as the prodigious treasure for Indian folk medicine. The study has focused on exploring the phytochemistry and antitumor potential of the C. infortunatum root extract in vitro and in vivo . The ethyl acetate root extract has demonstrated the highest cytotoxicity in a series of nine human tumor cell lines. Further fractionation of the same has yielded seven compounds. The structures of these compounds were confirmed with spectroscopic techniques. Considering the toxicity observed with the crude extract, cytotoxicity of these compounds was further assessed in two breast carcinoma cell lines (MCF-7[ER/PR-positive HER2-negative] and MDA-MB-231 [ER/PR/HER2-negative]) and in two cervical cancer [human papilloma virus (HPV)-negative C33A and HPV-positive SiHa] cell lines. Betulinic acid (BA) was found as the active principle contributing the cytotoxic activity, and cervical cancer cell lines documented the minimum IC 50 value in 24 h. In order to validate the in vitro experimental data, we have established a xenograft model of HPV-positive cervical cancer in female NOD/SCID mice treated with BA using doxorubicin as the positive control. BA treatment gradually reduced the tumor size, maintaining healthy hematological and biochemical parameters, and improved the survival rate of tumor-bearing mice considerably. Thus, our findings suggest that the C. infortunatum root extract has a promising anticancer property against HPV-positive cervical cancer and supports its usage by traditional healers for treating cervical cancer.
Keyphrases
- oxidative stress
- high grade
- endothelial cells
- breast cancer cells
- anti inflammatory
- induced pluripotent stem cells
- metabolic syndrome
- type diabetes
- pluripotent stem cells
- endoplasmic reticulum
- molecular dynamics simulations
- estrogen receptor
- cervical cancer screening
- combination therapy
- risk assessment
- artificial intelligence
- pi k akt
- cell cycle arrest